Acne Treatment Market Analysis

The global acne treatment market is likely to grow at a 5.3% CAGR between 2017-2023, as per the recent Market Research Future (MRFR) report. Acne is a common skin problem that can occur due to excessive oil production from the sebaceous glands, bad eating habits, unhealthy lifestyles, and fluctuating hormone levels. There are two common types of acne treatment- medication and therapeutic devices.

Numerous factors are adding to the global acne treatment market growth. These factors, according to the recent Market Research Future report, include a growing teenage population, rising prevalence of acne, increasing health consciousness, and also consciousness about the overall appearance. Additional factors adding to the global acne treatment market growth include increasing intake of high fatty dairy products and high sugar foods, no physical activity, consumption of fatty food, smoking and drinking habits, sedentary habits, rising incidence of hormone imbalance, increase in personal income, and FDA-approvals for acne treatment.

On the contrary, acute reactions and side effects from non-prescription products and the high price of therapeutic procedures such as dermabrasion, microdermabrasion, and others are factors that may impede the global acne treatment market growth during the forecast period.

Acne Treatment Market Segmentation

The Market Research Future report provides an all-inclusive segmental analysis of the global acne treatment market based on end users, treatment modality, treatment, and type.

By type, the global acne treatment market is segmented into post-surgical/wound acne, cystic acne, inflammatory acne, comedonal acne, and others. Of these, the inflammatory segment will lead the market during the forecast period.

By treatment, the global acne treatment market is segmented into therapeutic devices, medication, and others. The medication segment is again segmented into antibiotics, retinoid, and others. Retinoid is again segmented into tretinoin, adapalene, and others. Antibiotics are again segmented into clindamycin, erythromycin, and others. Therapeutic devices are again segmented into dermabradors, microdermabrader, lasers, and others. Of these, the medication segment will dominate the market during the forecast period.

By treatment modality, the global acne treatment market is segmented into injectable, topical, and oral.

By end users, the global acne treatment market is segmented into ambulatory surgical centers, pharmacies and drug stores, hospitals and clinics, and others.

Acne Treatment Market Regional Analysis

By region, the global acne treatment market report covers the latest trends and growth opportunities across the Americas, the Asia Pacific (APAC), Europe, and the Middle East and Africa (MEA). Of these, the Americas will spearhead the market during the forecast period for the presence of a huge patient population as well as a well-developed healthcare sector. Besides, increasing cosmetic expenditure and changing lifestyles are also adding to the acne treatment market growth in the region.

The acne treatment market in Europe is predicted to have the second-largest share in the market during the forecast period for the increasing teenage population, huge patient population, and availability of ample funds for R&D activities.

The acne treatment market in the APAC region will grow at the fastest pace during the forecast period for the presence of a developing healthcare sector, constantly developing economies such as China as well as India, and rising prevalence of acne.

The acne treatment market in the MEA will have a small share during the forecast period for the lack of healthcare services, strict government policies, and the presence of poor economies. In the Middle East, the acne treatment market will have steady growth for the huge healthcare expenditure by Kuwait, Dubai, and Saudi Arabia and the presence of a well-developed healthcare sector.

Acne Treatment Market Key Players

Leading players profiled in the global acne treatment market report include Roche Holding AG (Switzerland), Bayer AG (Germany), Teva Pharmaceutical Industries Ltd. (Israel), GlaxoSmithKline Plc. (U.K), Johnson & Johnson Services, Inc. (U.S.), Valeant (Canada), Stiefel Laboratories, Inc. (U.S.), Galderma S.A. (Switzerland), and ALLERGAN (Republic of Ireland). Key industry players have incorporated several strategies to strengthen their position in the market, such as extensive R&D, collaborations, mergers and acquisitions, strategic alliances, and others.

Browse Full Report with TOC at: https://www.marketresearchfuture.com/reports/acne-treatment-market-5675

Acne Treatment Industry News

February 2020- Sun Pharma has recently launched ABSORICA LD (isotretinoin), an acne treatment medication in the US. It will help to manage severe recalcitrant nodular acne in people aged 12 years and above. This acne drug will provide visibly, clearer skin in just five months.